Thalidezine - CAS 18251-36-0

Thalidezine, a novel AMPK activator, eliminates apoptosis-resistant cancer cells through energy-mediated autophagic cell death, it can inhibit the growth of mouse L1210 cells in vitro. Thalidezine possesses antimicrobial activity against Mycobacterium smegmatis at concentrations of 100 microgram/ml or less.

Apoptosis, AMPK

Chromatin/Epigenetic, Apoptosis, PI3K/Akt/mTOR signaling

18215

C38H42N2O7

638.761

[H][C@]12Cc3ccc(Oc4cc(C[C@]5([H])N(C)CCc6c(O)c(OC)c(OC)c(Oc7cc1c(CCN2C)cc7OC)c56)ccc4OC)cc3

-20°C

Ice Packs

Natural Product